
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Pharmacol. , 12 July 2019
Sec. Ethnopharmacology
Volume 10 - 2019 | https://doi.org/10.3389/fphar.2019.00779
A retraction of this article was approved in:
Retraction: Exploration of Multiple Signaling Pathways Through Which Sodium Tanshinone IIA Sulfonate Attenuates Pathologic Remodeling Experimental Infarction
Citation: Mao S, Vincent M, Chen M, Zhang M and Hinek A (2019) Exploration of Multiple Signaling Pathways Through Which Sodium Tanshinone IIA Sulfonate Attenuates Pathologic Remodeling Experimental Infarction. Front. Pharmacol. 10:779. doi: 10.3389/fphar.2019.00779
Received: 18 September 2018; Accepted: 17 June 2019;
Published: 12 July 2019; Retracted: 19 February 2025.
Edited by:
Sanjoy Ghosh, University of British Columbia Okanagan, CanadaDisclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.